TC BioPharm CEO, Bryan Kobel, is Featured on The Stock Day Podcast

<div>The Stock Day Podcast welcomed TC BioPharm Holdings, PLC. (NASDAQ:TCBP)(“the Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer with human efficacy data in acute myeloid leukemia. CEO of the Company, Bryan Kobel, joined Stock Day host Kevin Davis. </div>